Henrik Sundin Insider Trading
Director at Hamlet BioPharma AB 🇸🇪 — 6 insider transactions tracked from official Finansinspektionen filings.
Last updated: 2026-07-19 · Data sourced from MAR Article 19 regulatory disclosures
Live filings with conviction scores, signal badges, and post-trade return tracking across 16 markets.
All transactions
| Date | Type | Shares | Price | Value | Signals |
|---|---|---|---|---|---|
| 2026-05-25 | SELL | 10,000 | SEK 7 | SEK 74.9K | — |
| 2026-05-22 | SELL | 20,000 | SEK 8 | SEK 154.0K | — |
| 2026-05-22 | SELL | 20,000 | SEK 8 | SEK 153.0K | — |
| 2026-05-22 | SELL | 10,000 | SEK 8 | SEK 76.3K | — |
| 2026-05-22 | SELL | 10,000 | SEK 8 | SEK 76.1K | — |
| 2026-05-22 | SELL | 10,000 | SEK 8 | SEK 75.8K | — |
Frequently asked questions
Who is Henrik Sundin?
Henrik Sundin is Director at Hamlet BioPharma AB (Sweden). InsidersAlpha tracks Henrik Sundin's insider share transactions from official Finansinspektionen filings under MAR Article 19.
How many shares has Henrik Sundin bought or sold?
Henrik Sundin has made 6 insider transactions at Hamlet BioPharma AB, including 0 purchases and 6 sales worth €53.7K.
When did Henrik Sundin last trade Hamlet BioPharma AB stock?
Henrik Sundin's most recent filed transaction at Hamlet BioPharma AB was on 2026-05-25. InsidersAlpha updates daily from official Finansinspektionen disclosures.